Using polygenic risk scores to investigate the evolution of smoking and mental health outcomes in UK biobank participants
Acta Psychiatrica Scandinavica · 2023-11 · 148 (5) · 447-456
DOI: 10.1111/acps.13601 ↗At a glance
Journal article in Acta Psychiatrica Scandinavica, published online on 2023-08-21. Written by Lloyd Balbuena and 2 co-authors. Institution: Department of Psychiatry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada. Major MEDLINE topics: Multifactorial Inheritance, Schizophrenia, Hospitalization, Bipolar Disorder. Cited 11 times so far (Crossref); 50 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Oracle, Compute Canada, College of Medicine, University of Saskatchewan.
Abstract (original language)
Objective
Mendelian randomization studies report a bi‐directional relation between cigarette smoking and mental disorders, yet from a clinical standpoint, mental disorders are the focus of treatment. Here, we used an event history framework to understand their evolution in the life course. Our objective was to estimate the relative contribution of genetic predispositions and self‐reported smoking status (never, former, and present smoker) to hospitalizations for major depression, bipolar disorder, and schizophrenia.
Methods
We calculated polygenic risk scores (PRS) for ever smoking, pack‐years of smoking as a proportion of adult life, and neuroticism in 337,140 UK Biobank participants of white British ancestry. These PRS and self‐reported smoking status were entered as explanatory variables in survival models for hospitalization.
Results
The estimated single nucleotide polymorphisms heritabilities ( h 2 ) were 23%, 5.7%, and 5.7% for pack‐years, ever smoking, and neuroticism respectively. PRS pack‐years and PRS neuroticism were associated with higher hospitalization risk for mental disorders in all smoking status groups. The hazard for mental health hospitalization was higher in both previous (HR: 1.50, CI: 1.35–1.67) and current (HR: 3.58, 2.97–4.31) compared to never smokers, after adjusting for confounders.
Conclusion
Since genetic liabilities for smoking and neuroticism are fixed at conception and smoking initiation generally started before age 20, our results show that preventing smoking in adolescents probably prevents the development of mental disorders.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Psychiatry, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
- Center for Quantitative Genetics and Genomics, Aarhus University, Aarhus, Denmark.
ORCID profiles: Lloyd Balbuena
Funding
- Oracle
- Compute Canada
- College of Medicine, University of Saskatchewan
- College of Medicine, Catholic University of Korea
Cite
APA
Balbuena, L., Peters, E., & Speed, D. (2023). Using polygenic risk scores to investigate the evolution of smoking and mental health outcomes in UK biobank participants. Acta Psychiatrica Scandinavica, 148(5), 447-456. https://doi.org/10.1111/acps.13601
Vancouver
Balbuena L, Peters E, Speed D. Using polygenic risk scores to investigate the evolution of smoking and mental health outcomes in UK biobank participants. Acta Psychiatrica Scandinavica. 2023;148(5):447-456. doi:10.1111/acps.13601
BibTeX
@article{Balbuena2023,
author = {Balbuena, Lloyd and Peters, Evyn and Speed, Doug},
title = {Using polygenic risk scores to investigate the evolution of smoking and mental health outcomes in UK biobank participants},
journal = {Acta Psychiatrica Scandinavica},
year = {2023},
volume = {148},
number = {5},
pages = {447--456},
doi = {10.1111/acps.13601}
}
EUVIMED